Stock Events

Stock Events

Celldex Therapeutics (CLDX) Q4 2018 Earnings

7NovConfirmed

Q1 2018

Q2 2018

Q3 2018

Q4 2018

-3.59

-2.59

-1.6

-0.6

Details

Expected EPS

-2.22

Actual EPS

-0.6

Surprise EPS

1.62

Surprise Percent

+72.97%

Description

Celldex Therapeutics (CLDX) has reported earnings of -0.6 per share for Q4 2018.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.